Indivior Pharmaceuticals (INDV) Debt to Equity (2022 - 2025)
Historic Debt to Equity for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to -$1.56.
- Indivior Pharmaceuticals' Debt to Equity changed N/A to -$1.56 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.56, marking a year-over-year change of. This contributed to the annual value of -$0.99 for FY2024, which is 2424.33% up from last year.
- According to the latest figures from Q3 2025, Indivior Pharmaceuticals' Debt to Equity is -$1.56.
- Indivior Pharmaceuticals' 5-year Debt to Equity high stood at $4.71 for Q4 2022, and its period low was -$1.56 during Q3 2025.
- For the 4-year period, Indivior Pharmaceuticals' Debt to Equity averaged around -$0.26, with its median value being -$1.21 (2025).
- In the last 5 years, Indivior Pharmaceuticals' Debt to Equity crashed by 12771.74% in 2023 and then soared by 2424.33% in 2024.
- Quarter analysis of 4 years shows Indivior Pharmaceuticals' Debt to Equity stood at $4.71 in 2022, then plummeted by 127.72% to -$1.3 in 2023, then grew by 24.24% to -$0.99 in 2024, then crashed by 57.42% to -$1.56 in 2025.
- Its Debt to Equity stands at -$1.56 for Q3 2025, versus -$1.27 for Q2 2025 and -$1.15 for Q1 2025.